Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.

Sangeeta DhamiU NurmatovS ArasiT KhanMiqdad AsariaH ZamanA AgarwalG NetuveliG RobertsOliver PfaarA MuraroI J AnsoteguiM CalderonCemal CingiS DurhamR Gerth van WijkS HalkenE HamelmannP HellingsL JacobsenE KnolD Larenas-LinnemannS LinP MagginaR MösgesH Oude ElberinkG PajnoR PanwankarE PastorelloM PenagosC PitsiosG RotirotiF TimmermansO TsilochristouE-M VargaC Schmidt-WeberJ WilkinsonA WilliamsM WormL ZhangA Sheikh

Published in: Allergy (2017)

AIT is effective in improving symptom, medication, and combined symptom and medication scores in patients with allergic rhinoconjunctivitis while on treatment, and there is some evidence suggesting that these benefits are maintained in relation to symptom scores after discontinuation of therapy.

Keyphrases

allergic rhinitis
patient reported
healthcare
adverse drug
stem cells
emergency department
atopic dermatitis
replacement therapy